Concepedia

M. S. Marriott

MS

Statistics

Publications

21

Citations

1.1K

H-Index

17

Active since

1975

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

University of Edinburgh

M. S. Marriott is an author at Pfizer (United Kingdom) specializing in life sciences, microbiology, and mycology.

Publications per year

1975–2009

21

Publications

21

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes

Kenneth Richardson, K. W. Brammer, M. S. Marriott et al. · Antimicrobial Agents and Chemotherapy · 1985 · 166 citations · Full text

, , +13

Sordarins: A New Class of Antifungals with Selective Inhibition of the Protein Synthesis Elongation Cycle in Yeasts

Juan Manuel Domı́nguez, Valerie A. Kelly, O. S. KINSMAN et al. · Antimicrobial Agents and Chemotherapy · 1998 · 126 citations · Full text

, , +17

Isolation and Chemical Characterization of Plasma Membranes from the Yeast and Mycelial Forms of Candida Albicans

M. S. Marriott · Journal of General Microbiology · 1975 · 104 citations

, , +15

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice

Peter F. Troke, R. J. Andrews, K. W. Brammer et al. · Antimicrobial Agents and Chemotherapy · 1985 · 97 citations

, , +17

Inhibition of Sterol Biosynthesis in Candida albicans by Imidazole-containing Antifungals

M. S. Marriott · Microbiology · 1980 · 93 citations · Full text

, , +16

1–5 of 21